Florida Oncology Partners (Tables) (Florida Oncology Partners, LLC [Member])

9 Months Ended

Sep. 30, 2012

Florida Oncology Partners, LLC [Member]

Schedule of Equity Method Investments [Line Items]

Summarized financial information with respect to Florida Oncology Partners

Because the Company's interest in FOP may be considered significant relative to its other assets and operations, the following summarized financial information with respect to FOP is presented:

Florida Oncology Partners LLC Condensed Income Statement Information

	Nine Months Ended
	September 30,
	2012		2011
Net sales	$	2,322,000	$	1,110,000
Net income	$	364,000	$	86,000
USNC's equity in income of Florida Oncology Partners LLC	$	73,000	$	17,000
	Three Months Ended
	September 30,
		2012		2011
Net sales	$	839,000	$	465,000
Net income	$	178,000	$	390,000
USNC's equity in income of Florida Oncology Partners LLC	$	36,000	$	78,000

Florida Oncology Partners LLC Condensed Balance Sheet Information

	September 30,		December 31,
		2012		2011
Current assets	$	1,076,000	$	1,297,000
		.
Noncurrent assets		5,115,000		5,467,000
Total assets	$	6,191,000	$	6,764,000
Current liabilities	$	968,000	$	905,000
Noncurrent liabilities		4,416,000		4,944,000
Equity		807,000		915,000
Total liabilities and equity	$	6,191,000	$	6,764,000